A detailed history of Innovis Asset Management LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Innovis Asset Management LLC holds 136,755 shares of BSX stock, worth $12.4 Million. This represents 2.78% of its overall portfolio holdings.

Number of Shares
136,755
Previous 106,045 28.96%
Holding current value
$12.4 Million
Previous $5.74 Billion 25.88%
% of portfolio
2.78%
Previous 2.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$50.19 - $54.68 $1.54 Million - $1.68 Million
30,710 Added 28.96%
136,755 $7.22 Billion
Q2 2023

Aug 03, 2023

BUY
$49.72 - $54.64 $1.51 Million - $1.66 Million
30,340 Added 40.08%
106,045 $5.74 Billion
Q1 2023

May 10, 2023

BUY
$45.09 - $50.03 $1.07 Million - $1.18 Million
23,655 Added 45.45%
75,705 $3.79 Billion
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $2.06 Million - $2.46 Million
52,050 New
52,050 $2.41 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Innovis Asset Management LLC Portfolio

Follow Innovis Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Innovis Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Innovis Asset Management LLC with notifications on news.